SIRT4 and neoplasm: Both the transcriptional regulator C-terminal binding protein (CtBP) and the mammalian target of rapamycin complex 1 (mTORC1) (54) were discovered to promote glutamine metabolism and tumor proliferation in various cancer contexts by repressing the expression of Sirt4 directly (55) and indirectly (54), respectively (Figure 1E).